AVCNF
Price
$0.19
Change
+$0.01 (+5.56%)
Updated
Feb 21 closing price
Capitalization
18.52M
BIOYF
Price
$7.80
Change
-$0.01 (-0.13%)
Updated
Feb 21 closing price
Capitalization
66.94M
Ad is loading...

AVCNF vs BIOYF

Header iconAVCNF vs BIOYF Comparison
Open Charts AVCNF vs BIOYFBanner chart's image
Avicanna
Price$0.19
Change+$0.01 (+5.56%)
Volume$338K
Capitalization18.52M
BioSyent
Price$7.80
Change-$0.01 (-0.13%)
Volume$180
Capitalization66.94M
AVCNF vs BIOYF Comparison Chart
Loading...
View a ticker or compare two or three
VS
AVCNF vs. BIOYF commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVCNF is a Hold and BIOYF is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (AVCNF: $0.19 vs. BIOYF: $7.80)
Brand notoriety: AVCNF and BIOYF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AVCNF: 405% vs. BIOYF: 5%
Market capitalization -- AVCNF: $18.52M vs. BIOYF: $66.94M
AVCNF [@Pharmaceuticals: Other] is valued at $18.52M. BIOYF’s [@Pharmaceuticals: Other] market capitalization is $66.94M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVCNF’s FA Score shows that 0 FA rating(s) are green whileBIOYF’s FA Score has 2 green FA rating(s).

  • AVCNF’s FA Score: 0 green, 5 red.
  • BIOYF’s FA Score: 2 green, 3 red.
According to our system of comparison, BIOYF is a better buy in the long-term than AVCNF.

Price Growth

AVCNF (@Pharmaceuticals: Other) experienced а +9.77% price change this week, while BIOYF (@Pharmaceuticals: Other) price change was -0.19% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.14%. For the same industry, the average monthly price growth was +77.04%, and the average quarterly price growth was +50.35%.

Industries' Descriptions

@Pharmaceuticals: Other (-1.14% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
BIOYF($66.9M) has a higher market cap than AVCNF($18.5M). BIOYF YTD gains are higher at: 2.126 vs. AVCNF (-4.781). BIOYF has higher annual earnings (EBITDA): 7.42M vs. AVCNF (-13.98M). BIOYF has more cash in the bank: 26.2M vs. AVCNF (222K). BIOYF has less debt than AVCNF: BIOYF (1.35M) vs AVCNF (1.81M). BIOYF has higher revenues than AVCNF: BIOYF (27.4M) vs AVCNF (4.18M).
AVCNFBIOYFAVCNF / BIOYF
Capitalization18.5M66.9M28%
EBITDA-13.98M7.42M-189%
Gain YTD-4.7812.126-225%
P/E RatioN/A18.48-
Revenue4.18M27.4M15%
Total Cash222K26.2M1%
Total Debt1.81M1.35M134%
FUNDAMENTALS RATINGS
BIOYF: Fundamental Ratings
BIOYF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
27
SMR RATING
1..100
47
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
35
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AVDVX12.84-0.15
-1.15%
Avantis® International Small Cap Val Ins
GIFFX22.24-0.39
-1.72%
Invesco Growth and Income R6
VYRDX16.77-0.36
-2.10%
VY® Columbia Small Cap Value II R6
FAFGX76.62-1.84
-2.35%
American Funds Growth Fund of Amer 529F2
SSRRX6.32-0.19
-2.92%
Touchstone Small Company R6

AVCNF and

Correlation & Price change

A.I.dvisor tells us that AVCNF and PRFX have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCNF and PRFX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCNF
1D Price
Change %
AVCNF100%
+4.72%
PRFX - AVCNF
20%
Poorly correlated
-9.20%
ARSUF - AVCNF
12%
Poorly correlated
N/A
BSPK - AVCNF
9%
Poorly correlated
N/A
APNHY - AVCNF
7%
Poorly correlated
N/A
BKUH - AVCNF
5%
Poorly correlated
N/A
More

BIOYF and

Correlation & Price change

A.I.dvisor tells us that BIOYF and BUDZ have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIOYF and BUDZ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIOYF
1D Price
Change %
BIOYF100%
-0.06%
BUDZ - BIOYF
6%
Poorly correlated
-6.17%
AVCNF - BIOYF
1%
Poorly correlated
+4.72%
APNHY - BIOYF
0%
Poorly correlated
N/A
BSPK - BIOYF
0%
Poorly correlated
N/A
BIOVF - BIOYF
0%
Poorly correlated
N/A
More